Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Current Oncology Reports|April 2, 2008
Head and neck cancer immunotherapy: clinical evaluationMichael S Leibowitz, Jayakar V Nayak, Robert L FerrisCancer Immunology, Immunotherapy : CII|January 6, 2011
Deficiency of activated STAT1 in head and neck cancer cells mediates TAP1-dependent escape from cytotoxic T lymphocytesMichael S Leibowitz, Pedro A Andrade Filho, Soldano Ferrone, et al.Oral Oncology|May 16, 2009
Immunotherapy for head and neck cancerH Carter Davidson, Michael S Leibowitz, Andres Lopez-Albaitero, et al.Molecular Therapy Oncolytics|August 18, 2020
Analysis and Augmentation of the Immunologic Bystander Effects of CAR T Cell Therapy in a Syngeneic Mouse Cancer ModelAstero Klampatsa, Michael S Leibowitz, Jing Sun, et al.Molecular Diagnosis & Therapy|November 18, 2024
Leveraging Multi-omics to Disentangle the Complexity of Ovarian CancerShijuan Lin, Lily L Nguyen, Alexandra McMellen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2013
SHP2 is overexpressed and inhibits pSTAT1-mediated APM component expression, T-cell attracting chemokine secretion, and CTL recognition in head and neck cancer cellsMichael S Leibowitz, Raghvendra M Srivastava, Pedro A Andrade Filho, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
Alteration of cellular and humoral immunity by mutant p53 protein and processed mutant peptide in head and neck cancerMarion E Couch, Robert L Ferris, Joseph A Brennan, et al.Cancer Biology & Therapy|April 23, 2005
Regulatory T cells and cytokines in malignant pleural effusions secondary to mesothelioma and carcinomaPeter DeLong, Richard G Carroll, Adam C Henry, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 20, 2008
Enhancement in specific CD8+ T cell recognition of EphA2+ tumors in vitro and in vivo after treatment with ligand agonistsAmy K Wesa, Christopher J Herrem, Maja Mandic, et al.Cancer Research|November 3, 2007
Telomerase-specific T-cell immunity in breast cancer: effect of vaccination on tumor immunosurveillanceSusan M Domchek, Adri Recio, Rosemarie Mick, et al.Pageof 2